Bambusa Therapeutics Director Ra Capital Management L.P. Buys $46.6M of Stock
Ra Capital Management L.P., Director, bought 2,953,820 shares of Bambusa Therapeutics, Inc. at $14.23 to $16.00 a share (average $15.79) in 4 transactions, worth $46.6M in total between Oct 30, 2026 and Nov 2, 2026. Shares held after the trade: 1,495,971 (+12.4%).
Bambusa Therapeutics 10% Owner Investment GmbH Salvia Buys $6M of Stock
Investment GmbH Salvia, 10% Owner, bought 375,000 shares of Bambusa Therapeutics, Inc. at $16.00 a share, worth $6M in total on Nov 2, 2026. Shares held after the trade: 9,264,301 (+4.2%).
Bambusa Therapeutics Director Helmut Wolfgang Jeggle Buys $6M of Stock
Helmut Wolfgang Jeggle, Director, bought 375,000 shares of Bambusa Therapeutics, Inc. at $16.00 a share, worth $6M in total on Nov 2, 2026. Shares held after the trade: 9,264,301 (+4.2%).